PKR-dependent mechanisms of interferon-α for inhibiting hepatitis B virus replication

Mol Cells. 2011 Aug;32(2):167-72. doi: 10.1007/s10059-011-1059-6. Epub 2011 Jun 23.

Abstract

Interferon-α (IFN-α) inhibits the replication of hepatitis B virus (HBV) in vivo and in vitro, but the molecular mechanism of this inhibition has been elusive. We found that while HBV replication in transfected human hepatoma Huh-7 cell was severely inhibited by IFN-α treatment as reported previously, this inhibition was markedly impaired in the cell in which the expression of IFN-inducible, double-stranded RNA-dependent protein kinase (PKR) was stably and specifically suppressed through RNA-interference. Intracellular level of viral capsids was down-regulated likewise in a PKR-dependent manner, whereas that of HBV transcripts including the viral RNA pregenome was not affected by IFN-α treatment. Ectopic expression of PKR also resulted in the reduction of viral capsids with concomitant increase of phosphorylated eIF2α. These results suggested that PKR functions as a key mediator of IFN-α in opposing HBV replication, most likely through the inhibition of protein synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology*
  • Capsid / drug effects
  • Cell Line, Tumor
  • Eukaryotic Initiation Factor-2 / immunology
  • Eukaryotic Initiation Factor-2 / metabolism
  • Hepatitis B / drug therapy*
  • Hepatitis B / immunology
  • Hepatitis B / pathology
  • Hepatitis B virus / physiology*
  • Humans
  • Interferon-alpha / pharmacology*
  • Phosphorylation
  • RNA, Small Interfering / genetics
  • Signal Transduction / genetics
  • Signal Transduction / immunology
  • Transgenes / genetics
  • Virus Replication / genetics
  • eIF-2 Kinase / genetics
  • eIF-2 Kinase / immunology
  • eIF-2 Kinase / metabolism*

Substances

  • Antiviral Agents
  • Eukaryotic Initiation Factor-2
  • Interferon-alpha
  • RNA, Small Interfering
  • eIF-2 Kinase